In addition to the apoptotic effects described above, it seemed possible that the decrease in viable cell numbers in ER+veMYB+ve breast cancer cells treated with CDK9i may also reflect direct inhibition of proliferation; this would be at least consistent with visual inspection (e.g. Figure 2D). Here, ESR1 is linked to breast carcinoma.